Rechtsanwalt, Michael Eggersberger

GSK Stockmann advises a pension fund on the sale of Wacker Chemie AG headquarters in Munich to Blue Colibri Capital

GSK Stockmann advised the Munich-based pension fund Wacker Chemie VVaG, which owns Wacker Chemie AG’s headquarters in Munich-Neuperlach, on the sale of the building to Blue Colibri Capital, a private equity firm based in Luxembourg.

The building at Hanns-Seidel-Platz in Neuperlach has 48,000 sqm of floor space spread over five floors, 90% of which is used by Wacker Chemie AG; the rest is sublet. The chemical company has been using the building ever since it was completed in 1991, but is moving to new facilities at the end of 2023. Wacker Chemie AG is the parent company of a globally operating chemical group founded in 1914.

The Luxembourg-based private equity company Blue Colibri Capital has acquired the Wacker Chemie headquarters for one of its real estate funds. The value-add investor Blue Colibri wants to reposition and re-let the 31-year-old building.

Advisers of Pensionskasse Wacker Chemie VVaG:

GSK Stockmann: Michael Eggersberger (lead, real estate transactions and investments), Mark Butt (public law), Felix Bergfort (real estate law), Dominik Berka (tax law); Associate: Karolin Streser (both real estate law)

Download
Print
Press contact

Contact person